Replies to post #110167 on Biotech Values

[y3maxx]

Teva -- Yoram Gabisom, reporter

...Gabisom does not utilize quotation marks...He is a free spirit Journalist...

http://www.haaretz.com/print-edition/business/oppenheimer-raises-teva-outlook-to-outperform-1.313680

http://www.haaretz.com/print-edition/business/court-rejects-rivals-motion-to-void-patents-on-teva-s-copaxone-1.312845

http://www.haaretz.com/print-edition/business/a-new-threat-to-teva-s-copaxone-looms-large-cladribine-pill-from-merck-for-multiple-sclerosis-1.304909

Quotations used only with Tal Levy, co writer...

http://www.haaretz.com/print-edition/business/teva-plays-down-drug-price-pressures-1.304474

and finally...

July 25th

Teva plummets 8.7% as FDA sets generic testing precedent

http://www.haaretz.com/print-edition/business/teva-plummets-8-7-as-fda-sets-generic-testing-precedent-1.303859

Teva's S P dropped nearly 9% after M enonx approval...Is it any wonder Teva is pulling out all the stops vs MNTA?

y3

[acgood]

Whether or not Teva's manufacturing infringes on MNTA's patent absolutely would not be discussed in a meeting between TEVA and FDA, and the FDA would/will be in no way making any claim or determination of whether or not there is patent infringement.

[genisi]

...but if someone (hello genisi) was able to get a hold of the reporter and corroborate...

Hello dewophile, you've made me look for the original piece by Yoram G. and it doesn't contain this part of that sentence - "...and does not copy the Momenta method." anywhere. There are some other differences between the Hebrew and English versions but I don't read too much into things written by journalists and then, as if it is not enough, translated by amateurs.